Maybe someday the retail investor will see some of the

New Post Public Reply Private Reply Replies (0) Message Board
dandaman53
Maybe someday the retail investor will see some of the thieves get their day!
(need registration for link)
The Securities and Exchange Commission is considering a change that would require some defendants to admit wrongdoing when they have engaged in “egregious misconduct” – a move that would represent a shift away from a decades-long policy.
In a memo to enforcement attorneys, George Canellos and Andrew Ceresney, co-directors of the SEC’s enforcement division, said that “most” cases would continue to be settled with defendants not admitting or denying wrongdoing, as has been the policy since the 1970s. But in a shift, they said there were certain cases where “admissions could be in the public interest”.
“These may include misconduct that harmed large numbers of investors or placed investors or the market at risk of potentially serious harm; where admissions might safeguard against risks posed by the defendant to the investing public, particularly when the defendant engaged in egregious intentional misconduct; or when the defendant engaged in unlawful obstruction of the commission’s investigative processes,” the directors wrote.
Any change in policy is likely to require agreement by a majority of the SEC’s five commissioners.
The commission has faced criticism from judges overseeing some settlements that it is looking for a rubber stamp for judgments that may not be just, fair or in the public interest.
The most high-profile critique was when Judge Jed Rakoff in 2011 refused to approve the SEC’s settlement with Citigroup over its sale of a collateralised mortgage product. A US appeals court is considering the issue but has signalled it may side with the SEC, citing the deference afforded to administrative agencies.
After the backlash, the SEC said it would no longer agree to no-admit, no-deny settlements when an entity or individual admitted wrongdoing in criminal cases. The memorandum to staff takes the issue further.
The SEC has argued it is more efficient to settle cases without requiring admissions of wrongdoing because of the risk of litigation and the resources required to focus on older cases rather than uncovering new frauds.
In positing the new framework, the co-directors said if there was a case that qualified for admission it would be worth litigating.
In a nod to the judicial criticisms, the SEC enforcement chiefs said: “We will also continue to strongly defend our discretion to reach such settlements in response to inquiries from courts.”
The directors said there would be a meeting with the hundreds of enforcement staffers to solicit their views. They also asked the staff to look at their inventory of cases to review whether any “warrant consideration of public acceptance of responsibility by the defendant(s)”.

Treaty Energy Corporation (TECO) Stock Research Links

TECO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Deadline Looms for EquipmentShare Investors' Legal Action

Updated Category News Views 3

Pressure Builds for EquipmentShare Investors If you've thrown some cash into EquipmentShare.com Inc. (NASDAQ: EQPT), it's time to sit up and pay attention. There's smoke on the horizon, and Faruqi & Faruqi, LLP is waving the flag. They've got a securities class action spinning fast, and if you've suffered any losses, September 21, 2026, is a date you don't want to forget....

Continue Reading
K-9 Hero Act Aims to Ease Costs for Retired Dogs' Care

Updated Category News Views 6

Let's Talk About the Loyalty that Dogs Deserve Who would've thought we'd be chatting about our four-legged heroes in a federal setting? But here we are, giving well-deserved attention to those furry federal agents. They're the ones who sniff out bombs and tackle crooks, and they're not asking for a retirement plan with a yacht – just some vet care! What the K-9 Hero Act...

Continue Reading
AbbVie's Bold Leap in Menstrual Migraine Treatment

Updated Category News Views 10

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...

Continue Reading
Unpacking RAGEism: Power Dynamics in U.S. Policies

Updated Category News Views 3

Seeing Patterns in Crisis: Jackson and Flint When Jackson, Mississippi's latest water crisis hit the news, it wasn't the first time folks were left high and dry. No, this fiasco's got deep roots, and it resonates with another infamous case: Flint, Michigan. In Maya Rockeymoore Cummings' book, RAGEism, these are badge-worthy examples of 'Resource Hoarding' where government...

Continue Reading
Atli Launches: AI-Powered eSIM Revolutionizes Travel

Updated Category News Views 4

What's New in Travel Tech: Atli's Debut Wandering the globe might sound romantic until you realize your phone's a paperweight without the right data. Enter Atli, a shiny new AI-powered travel eSIM service, snugged right into your WhatsApp. This marvel comes from the folks at XForge Mobile and aims to obliterate the hassle of getting connected abroad. You know those...

Continue Reading
Red-Eye Flights Surge, Driven By Western U.S. Routes

Updated Category News Views 4

You can always count on some things staying the same, right? Well, if you thought red-eye flights were going to fade away, think again. These late-night wonders are not just hanging around—they're booming in the west like there's no tomorrow. Literally. Champion Traveler has laid it all out for us: about 115,580 overnight flights in 2025, a record high since this mad...

Continue Reading
GBI Bio's New CEO Jesse McCool to Propel Growth

Updated Category News Views 4

Jesse McCool stepping into GBI's CEO shoes is the kind of move that makes you sit up straight and take notice. Let me tell you, the biomanufacturing scene is buzzing with this appointment, and McCool's got his work cut out for him in leading GBI Biomanufacturing's shift towards commercial-scale operations while expanding their early-stage biotech portfolio. A Veteran in...

Continue Reading
Step Inside Henson's Creature Shop Magic in NYC

Updated Category News Views 1

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 1

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
SES Sells to AFC Industries: A Strategic M&A Move

Updated Category News Views 0

Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...

Continue Reading

Top 5 Most Recently Viewed Articles

Cardiovalve Targets CE Mark for Advanced Heart Valve Solutions

Updated Category News Views 402

Significant Milestone for Cardiovalve's Heart Valve Programs The Company Advances Toward European CE Mark Submission with 150 Patients Enrolled; On Track for 2027 Commercial Launch Recently, Cardiovalve, a prominent player in transcatheter valve replacement technology, successfully completed patient enrollment for the groundbreaking Cardiovalve TARGET study focused on...

Continue Reading
Inflammatix Strengthens Leadership Team with New Executives

Updated Category News Views 190

Inflammatix Expands Leadership Team Inflammatix, a leader in molecular diagnostics, has made significant strides by adding three industry veterans to its executive leadership team. This strategic expansion is aimed at spearheading the commercialization of the company's flagship product, the TriVerity™ Test. The newly appointed executives include Dr. Sam Ajizian as Chief...

Continue Reading
Understanding Bitcoin Treasury Holdings and Market Impacts

Updated Category News Views 160

The Dynamics of Bitcoin and Treasury Companies In recent months, the activity surrounding Bitcoin has captured the financial world's attention, especially with treasury companies increasingly acquiring substantial amounts of BTC. However, despite this significant uptick in investment, the anticipated price escalation has not occurred as expected. Trends in Corporate...

Continue Reading
Trump Promises Legal Action Against Google if Elected

Updated Category News Views 108

Back in 2024, Donald Trump threw down the gauntlet on Google (NASDAQ: GOOGL) during a Truth Social update, claiming he'd go after them legally if he won the presidency. This wasn’t just some offhand comment; it was a calculated move that tied into his broader campaign strategy as he sought to rally his base around claims of media bias. Media Bias or Political Theater?...

Continue Reading
Upcoming Earnings Report Analysis for Asana (NYSE: ASAN)

Updated Category News Views 139

Asana's Earnings Preview Asana (NYSE: ASAN) is set to release its quarterly earnings report soon, generating anticipation among investors. Understanding the key insights prior to the announcement can be vital for making informed investment decisions. Analysts have estimated that the company could report an earnings per share (EPS) of $-0.03. The Market's Expectations...

Continue Reading